NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Teon Therapeutics

Teon Therapeutics

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://teontherapeutics.com/

Last Round

Series A

Feb 22, 2021

Est. Valuation

$63.7M

Total Funding Raised

$37.27M

Company Overview

Teon Therapeutics is a biotechnology company that develops single-target small molecules aimed at restoring antitumor immunity and inhibiting cancer cell growth.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncologysmall-molecule therapyimmune response modifierbiotechcancer immunotherapyclinical trialstumor microenvironmentdrug developmentcheckpoint inhibitorbiopharmadrug discoveryoral therapeuticsclinical-stageGPCR antagonist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Teon Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Teon Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 22, 2021
DebtApr 15, 2020
SeedJan 24, 2019

Key People

Founding team and executive leadership

Lina Yao

Founder, President And Interim CEO

Founding Team

Teon Therapeutics Investors

Notable investors and investment history

InvestorRounds
Oriental Fortune CapitalSeries A, Seed
Kaitai CapitalSeries A, Seed
Northern Light Venture CapitalSeries A, Seed
Oceanpine CapitalSeries A
Oriza VenturesSeries A
Oriza VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2021

    Raised $30M Series A round

Teon Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Teon Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Teon Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range7
Year Founded2018
Last FundingFeb 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.